Introduction
For foreign fragrance and perfume brands entering the U.S., the practical question is usually not whether MoCRA applies, but which parts apply now versus later. Perfume is generally regulated as a cosmetic when it is marketed to cleanse, beautify, or alter appearance, which means the current compliance work is facility registration, product listing, labeling discipline, and role assignment under MoCRA rather than waiting on future rulemaking. FDA fragrance guidance
The point that trips up many importers is fragrance allergen disclosure. MoCRA created a statutory framework for FDA to require allergen disclosure on cosmetic labels, but the rule identifying which allergens must be named and at what thresholds is still not final. As of July 28, 2026, FDA’s Unified Agenda entry still shows the proposal at the proposed-rule stage with a target of May 2026, so this is best treated as a coming requirement, not current law. Reginfo Unified Agenda
This page is for fragrance houses, private-label perfume brands, and beauty importers that need to launch or keep selling in the U.S. without confusing today’s filing obligations with tomorrow’s label changes.
What applies to fragrance and perfume now
MoCRA’s current operating burden for most perfume brands is straightforward: make sure the manufacturing or processing facility is registered if required, make sure each marketed cosmetic product is listed if required, and make sure the label already meets the cosmetic rules that exist today. FDA’s registration and listing system for cosmetics is live through Cosmetics Direct, with SPL-based submission options also available. FDA registration and listing page
- Facility registration: Cosmetic manufacturers and processors selling into the U.S. generally need facility registration under MoCRA.
- Product listing: Each marketed cosmetic product generally needs a product listing, including ingredient information.
- Label basics: Existing cosmetic labeling rules still matter now, including ingredient declaration rules, net quantity, and the name and place of business.
- Responsible Person: A cosmetic product needs a Responsible Person for safety and labeling accountability; that role is separate from the FDA U.S. Agent for a foreign facility.
Current requirement vs coming requirement
| Issue | Status for fragrance/perfume importers | What to do now |
|---|---|---|
| Cosmetic facility registration | Current requirement for covered facilities | Confirm the manufacturing/processing site is registered and tied to the right U.S. contact structure |
| Cosmetic product listing | Current requirement for covered products | List each marketed fragrance product with its ingredient information and maintain updates on the required cadence |
| Ingredient declaration under current cosmetic rules | Current requirement | Review label format, ingredient naming, and ordering before launch |
| Fragrance allergen disclosure | Not final yet | Prepare source documentation and label-change workflows, but do not treat it as already mandatory U.S. label text |
| Responsible Person vs U.S. Agent assignment | Current structural requirement | Do not assume one role automatically satisfies the other |
The fragrance allergen rule is coming, but it is not in force yet
Here is the clean distinction buyers need: current U.S. cosmetic product listings already include ingredient information, including fragrances, flavors, or colors, but that is not the same thing as a finalized consumer-facing fragrance allergen label rule. The future rule is expected to identify specific fragrance allergens and require disclosure above defined thresholds; until FDA finalizes that rule, brands should avoid acting as if a definitive U.S. allergen list already exists for cosmetics. Cornell LII, 21 U.S.C. 364c
That matters especially for perfume brands because many already work with EU or IFRA-oriented documentation and may assume U.S. law has already caught up. It has not. MoCRA created the authority, and the statute says the responsible person must identify fragrance allergens on the label through regulations implementing that subsection, but the operational details still depend on FDA rulemaking. U.S. Code, 21 U.S.C. 364e
Who this matters to most
This issue is most acute for three kinds of importers:
- Indie or founder-led perfume brands that are launching into the U.S. for the first time and need to separate MoCRA basics from future label changes.
- Private-label fragrance sellers that rely on contract manufacturers and need clarity on who handles facility registration, product listing, and Responsible Person duties.
- Established international beauty brands that already comply with EU-style fragrance documentation and need to avoid over-translating foreign requirements into U.S. labels before FDA finalizes its own rule.
Common mistakes fragrance importers make
Assuming “fragrance” on the label solves the future allergen issue
It does not. Current cosmetic labeling can still permit ingredients to be declared generally as fragrance or perfume in some contexts, and FDA explicitly notes that certain fragrance formula components may cause allergic reactions while the agency does not yet have the same allergen-labeling authority for cosmetics that it has for food without the implementing rule. FDA allergens in cosmetics
Confusing the Responsible Person with the U.S. Agent
This is a recurring MoCRA failure mode. The Responsible Person is the entity legally accountable for cosmetic product safety and labeling compliance, while the U.S. Agent is the FDA’s U.S.-based contact for a foreign facility. Foreign fragrance brands often need both roles addressed, especially when manufacturing sits overseas and the brand owner is not U.S.-based. FDA Entry Point cosmetic FAQs
Waiting for the allergen rule before doing current filings
That is the wrong sequence. Registration and listing are already live, and FDA has continued updating the portal and guidance materials, including 2026 updates tied to biennial renewal preparation. FDA cosmetics portal updates
Letting marketing claims turn a perfume into a drug issue
Fragrance brands sometimes drift into claims about mood, stress, sleep, hormone effects, or therapeutic benefit. Once claims suggest treatment, prevention, or structure/function effects, the regulatory posture can change materially. That is often where a simple cosmetic launch becomes a much harder filing problem. FDA Entry Point label review page
Where the exemption analysis gets tricky
Some small businesses are exempt from certain MoCRA requirements, including registration and listing, but that exemption is not universal and does not erase the rest of cosmetic law. FDA notes that small-business exemptions do not apply the same way for certain higher-risk categories, including products intended for internal use. For fragrance and perfume brands, this means exemption analysis should be done carefully rather than assumed from company size alone. FDA small business fact sheet
In practice, most importers should treat “we are small” as a question to validate, not a shortcut that lets them skip the filing workflow.
Where FDA Entry Point fits
FDA Entry Point is built for foreign manufacturers and importers that need more than a mailbox-style U.S. Agent. On the cosmetics side, the company handles U.S. Agent support, cosmetic facility registration, cosmetic product listing, Responsible Person services, label review, and renewal tracking under one workflow. That is a stronger fit for fragrance brands that do not have an in-house regulatory operator and want one team managing both the filing mechanics and the role distinctions that MoCRA introduced. FDA Entry Point cosmetics services
It is especially relevant when the documents get messy: multiple SKUs, overseas manufacturing, uncertainty over who should be the Responsible Person, or labels that may need to adapt once FDA finalizes the fragrance allergen rule. FDA Entry Point also explicitly notes that a foreign Responsible Person may still need a U.S. Agent, which is one of the more common confusion points for cosmetic importers. FDA Entry Point cosmetics explainer
A practical launch checklist for perfume brands
- Confirm the product is being marketed as a cosmetic, not with drug-like therapeutic claims.
- Map the legal roles: manufacturer, Responsible Person, U.S. Agent, importer, and distributor.
- Verify whether the manufacturing or processing facility must be registered.
- Prepare product listings with ingredient information for each marketed fragrance SKU.
- Review current labels for ingredient declaration, mandatory business information, and other cosmetic basics.
- Collect fragrance composition and supplier documentation now so future allergen-rule changes are easier to implement.
References
- FDA — Registration & Listing of Cosmetic Product Facilities and Products
- Reginfo — Disclosure of Fragrance Allergens in Cosmetic Labeling
- FDA — Fragrances in Cosmetics
- FDA — Allergens in Cosmetics
- FDA — Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
- Cornell Legal Information Institute — 21 U.S.C. 364c
- U.S. Code — 21 U.S.C. 364e
- FDA — Small Businesses & Homemade Cosmetics Fact Sheet
- FDA Entry Point — FDA Cosmetic Compliance Services
- FDA Entry Point — Cosmetic FAQs
- FDA Entry Point — Cosmetic Label Review (INCI) & Claims
- FDA Entry Point AI Surface — FDA U.S. Agent & Registration for Foreign Cosmetic Brands (MoCRA)